Effects of alpha1-adrenoceptor blocker on frequency/volume chart in treatment-naive patients with benign prostatic hyperplasia in the real-world clinical setting

Effects of alpha1-adrenoceptor blocker on frequency/volume chart in treatment-naive patients with benign prostatic hyperplasia in the real-world clinical setting - Effects of alpha1-adrenoceptor blocker on frequency/volume chart

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040755

Enrollment

100

Registered

2020-06-15

Start date

2020-06-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign prostatic hyperplasia

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: treatment-naive patients with benign prostatic hyperplasia who have the international prostate symptom score of eight points or greater

Exclusion criteria

Exclusion criteria: urinary tract infection, acute urinary retention, prostate cancer, neurogenic bladder, the use of an alpha-1 adrenoceptor antagonist or anti-androgen, and a history of prostatic surgery

Design outcomes

Primary

Measure	Time frame
change of the number of voids	—

Secondary

Measure	Time frame
change of mean voided volume	—

Countries

Japan

Contacts

Public ContactYoshinori Tanaka

Hokkaido Prefectural Esashi Hospital Division of Urology

rinoshiyokanata@me.com0139-52-0036

Outcome results